These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 31123340)

  • 1. Testosterone replacement therapy and cardiovascular risk.
    Gagliano-Jucá T; Basaria S
    Nat Rev Cardiol; 2019 Sep; 16(9):555-574. PubMed ID: 31123340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events.
    Kharaba ZJ; Buabeid MA; Ibrahim NA; Jirjees FJ; Obaidi HJA; Kaddaha A; Khajehkarimoddini L; Alfoteih Y
    Biomed Pharmacother; 2020 Sep; 129():110423. PubMed ID: 32570122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.
    Jones TH; Kelly DM
    Asian J Androl; 2018; 20(2):120-130. PubMed ID: 29442075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trials of testosterone replacement reporting cardiovascular adverse events.
    Gagliano-Jucá T; Basaria S
    Asian J Androl; 2018; 20(2):131-137. PubMed ID: 28782738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks and benefits of testosterone therapy in older men.
    Spitzer M; Huang G; Basaria S; Travison TG; Bhasin S
    Nat Rev Endocrinol; 2013 Jul; 9(7):414-24. PubMed ID: 23591366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.
    Haddad RM; Kennedy CC; Caples SM; Tracz MJ; Boloña ER; Sideras K; Uraga MV; Erwin PJ; Montori VM
    Mayo Clin Proc; 2007 Jan; 82(1):29-39. PubMed ID: 17285783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone and the Heart.
    Goodale T; Sadhu A; Petak S; Robbins R
    Methodist Debakey Cardiovasc J; 2017; 13(2):68-72. PubMed ID: 28740585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of testosterone therapy in hypogonadal patients and its controversial adverse impact on the cardiovascular system.
    Kharaba ZJ; Buabeid MA; Alfoteih YA
    Crit Rev Toxicol; 2020 Jul; 50(6):491-512. PubMed ID: 32689855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone Replacement Therapy and Mortality in Older Men.
    Hackett GI
    Drug Saf; 2016 Feb; 39(2):117-30. PubMed ID: 26482385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between testosterone replacement therapy and cardiovascular outcomes: A meta-analysis of 30 randomized controlled trials.
    Jaiswal V; Sawhney A; Nebuwa C; Borra V; Deb N; Halder A; Rajak K; Jha M; Wajid Z; Thachil R; Bandyopadhyay D; Mattumpuram J; Lavie CJ
    Prog Cardiovasc Dis; 2024; 85():45-53. PubMed ID: 38589271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone treatment in the aging male: myth or reality?
    Nigro N; Christ-Crain M
    Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone deficiency and cardiovascular mortality.
    Morgentaler A
    Asian J Androl; 2015; 17(1):26-31. PubMed ID: 25432501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased Risk.
    Khera M; Miner M; Jaffe J; Pastuszak AW
    J Sex Med; 2021 Jan; 18(1):83-98. PubMed ID: 33317996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone treatment and cardiovascular events in prescription database studies.
    Shores MM
    Asian J Androl; 2018; 20(2):138-144. PubMed ID: 28816202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone and cardiovascular risk in men.
    Kelly DM; Jones TH
    Front Horm Res; 2014; 43():1-20. PubMed ID: 24943294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgens and cardiovascular disease.
    Yeap BB
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):269-76. PubMed ID: 20186051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Testosterone Replacement Therapy and the Incidence of a Composite of Postoperative In-Hospital Mortality and Cardiovascular Events in Men Undergoing Cardiac Surgery.
    Argalious MY; Steib J; Daskalakis N; Mao G; Li M; Armanyous S; Roselli E
    Anesth Analg; 2020 Apr; 130(4):890-898. PubMed ID: 30896595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset hypogonadism: Reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy.
    Sesti F; Pofi R; Minnetti M; Tenuta M; Gianfrilli D; Isidori AM
    Andrology; 2020 Nov; 8(6):1614-1627. PubMed ID: 32737921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone therapy and the risk of cardiovascular disease in older, hypogonadal men.
    Krishnan S; Aldana-Bitar J; Golub I; Ichikawa K; Shabir A; Bagheri M; Hamidi H; Benzing T; Kianoush S; Budoff MJ
    Prog Cardiovasc Dis; 2024; 84():14-18. PubMed ID: 38423237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency.
    Cheetham TC; An J; Jacobsen SJ; Niu F; Sidney S; Quesenberry CP; VanDenEeden SK
    JAMA Intern Med; 2017 Apr; 177(4):491-499. PubMed ID: 28241244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.